GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Suisse Corp (OTCPK:CSUI) » Definitions » EV-to-EBITDA

Cannabis Suisse (Cannabis Suisse) EV-to-EBITDA : -10.71 (As of May. 27, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cannabis Suisse EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cannabis Suisse's enterprise value is $2.51 Mil. Cannabis Suisse's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 was $-0.23 Mil. Therefore, Cannabis Suisse's EV-to-EBITDA for today is -10.71.

The historical rank and industry rank for Cannabis Suisse's EV-to-EBITDA or its related term are showing as below:

CSUI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -385.64   Med: -6.88   Max: -1.33
Current: -10.71

During the past 8 years, the highest EV-to-EBITDA of Cannabis Suisse was -1.33. The lowest was -385.64. And the median was -6.88.

CSUI's EV-to-EBITDA is ranked worse than
100% of 715 companies
in the Drug Manufacturers industry
Industry Median: 14.57 vs CSUI: -10.71

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), Cannabis Suisse's stock price is $0.0224. Cannabis Suisse's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was $-0.003. Therefore, Cannabis Suisse's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Cannabis Suisse EV-to-EBITDA Historical Data

The historical data trend for Cannabis Suisse's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Suisse EV-to-EBITDA Chart

Cannabis Suisse Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23
EV-to-EBITDA
Get a 7-Day Free Trial -1,923.24 -65.02 -7.69 -7.31 -11.77

Cannabis Suisse Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.08 -11.77 -6.30 -4.96 -9.28

Competitive Comparison of Cannabis Suisse's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Suisse's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Suisse's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Suisse's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cannabis Suisse's EV-to-EBITDA falls into.



Cannabis Suisse EV-to-EBITDA Calculation

Cannabis Suisse's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2.505/-0.234
=-10.71

Cannabis Suisse's current Enterprise Value is $2.51 Mil.
Cannabis Suisse's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Suisse  (OTCPK:CSUI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Cannabis Suisse's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0224/-0.003
=At Loss

Cannabis Suisse's share price for today is $0.0224.
Cannabis Suisse's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.003.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Cannabis Suisse EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cannabis Suisse's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Suisse (Cannabis Suisse) Business Description

Traded in Other Exchanges
N/A
Address
10 North Neuman Street, Suite A, Jacksonville, FL, USA, 32202
Cannabis Suisse Corp is engaged in the rental of commercial office and industrial space.
Executives
Scott Walker Mcalister director, 10 percent owner, officer: CEO/CFO 10 NORTH NEWNAN STREET, SUITE A, JACKSONVILLE FL 32202